BackPOINT Biopharma Global Overview
POINT Biopharma Global Inc

POINT Biopharma Global Target Price

See how PNT's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.5

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2022-12-14Raymond James$1020% downsideOpen
2022-11-30Leerink Partners$1412% upsideOpen
2022-11-15Truist Financial$1412% upsideOpen
2022-09-18Piper SandlerEdward Tenthoff$1736% upsideOpen
2022-09-11Piper SandlerEdward Tenthoff$1952% upsideOpen

POINT Biopharma Global (PNT) FAQ

Stockcircle tracks target price for POINT Biopharma Global (PNT), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for POINT Biopharma Global's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main PNT overview so you can move from this figure to the surrounding analysis quickly.